C. R. Bard, Inc. (U.S.)
Becton, Dickinson and Company (U.S.)
Cook Group Incorporated (U.S.)
Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
Argon Medical Devices (U.S.)
B. Braun Melsungen AG (Germany)
Cardinal Health, Inc. (U.S.)
Olympus Corporation (Japan)
Boston Scientific Corporation (U.S.)
FUJIFILM Holdings Corporation (Japan)
INRAD, Inc. (U.S.)
Medtronic plc (Ireland)
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT INDUSTRY
2.1 Summary about Stereotactic-guided Biopsy Instrument Industry
2.2 Stereotactic-guided Biopsy Instrument Market Trends
2.2.1 Stereotactic-guided Biopsy Instrument Production & Consumption Trends
2.2.2 Stereotactic-guided Biopsy Instrument Demand Structure Trends
2.3 Stereotactic-guided Biopsy Instrument Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Needle-based Biopsy Instruments
4.2.2 Localization Wires
4.2.3 Procedure Trays
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Breast Biopsy
4.3.2 Lung Biopsy
4.3.3 Colorectal Biopsy
4.3.4 Prostate Biopsy
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Needle-based Biopsy Instruments
5.2.2 Localization Wires
5.2.3 Procedure Trays
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Breast Biopsy
5.3.2 Lung Biopsy
5.3.3 Colorectal Biopsy
5.3.4 Prostate Biopsy
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Needle-based Biopsy Instruments
6.2.2 Localization Wires
6.2.3 Procedure Trays
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Breast Biopsy
6.3.2 Lung Biopsy
6.3.3 Colorectal Biopsy
6.3.4 Prostate Biopsy
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Needle-based Biopsy Instruments
7.2.2 Localization Wires
7.2.3 Procedure Trays
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Breast Biopsy
7.3.2 Lung Biopsy
7.3.3 Colorectal Biopsy
7.3.4 Prostate Biopsy
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Needle-based Biopsy Instruments
8.2.2 Localization Wires
8.2.3 Procedure Trays
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Breast Biopsy
8.3.2 Lung Biopsy
8.3.3 Colorectal Biopsy
8.3.4 Prostate Biopsy
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Needle-based Biopsy Instruments
9.2.2 Localization Wires
9.2.3 Procedure Trays
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Breast Biopsy
9.3.2 Lung Biopsy
9.3.3 Colorectal Biopsy
9.3.4 Prostate Biopsy
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 C. R. Bard, Inc. (U.S.)
10.1.2 Becton, Dickinson and Company (U.S.)
10.1.3 Cook Group Incorporated (U.S.)
10.1.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
10.1.5 Argon Medical Devices (U.S.)
10.1.6 B. Braun Melsungen AG (Germany)
10.1.7 Cardinal Health, Inc. (U.S.)
10.1.8 Olympus Corporation (Japan)
10.1.9 Boston Scientific Corporation (U.S.)
10.1.10 FUJIFILM Holdings Corporation (Japan)
10.1.11 INRAD, Inc. (U.S.)
10.1.12 Medtronic plc (Ireland)
10.2 Stereotactic-guided Biopsy Instrument Sales Date of Major Players (2017-2020e)
10.2.1 C. R. Bard, Inc. (U.S.)
10.2.2 Becton, Dickinson and Company (U.S.)
10.2.3 Cook Group Incorporated (U.S.)
10.2.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
10.2.5 Argon Medical Devices (U.S.)
10.2.6 B. Braun Melsungen AG (Germany)
10.2.7 Cardinal Health, Inc. (U.S.)
10.2.8 Olympus Corporation (Japan)
10.2.9 Boston Scientific Corporation (U.S.)
10.2.10 FUJIFILM Holdings Corporation (Japan)
10.2.11 INRAD, Inc. (U.S.)
10.2.12 Medtronic plc (Ireland)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
